Goldman Sachs:
- Reiterated Outperform on DNA and A.
- Reiterated Outperform on RIMM, sees 30% upside.
Smith Barney:
- Reiterated Buy on RIMM, target $96.
- Reiterated Buy on WY, target $75.
- Reiterated Buy on SEBL, target $11.
- Reiterated Buy on CSCO, target $30.
- Reiterated Buy on BJS, target $62.
- Reiterated Buy on MEE, target $54.
Morgan Stanley:
- Raised PFE to Overweight, target $32.
- Reinstated ATG Overweight, target $40.
- Said steel prices may fall in the second half, ending six straight quarters of increases, as demand growth slows in China, the US and Europe.
- Reiterated Overweight on CP, target $40.
- Reiterated Overweight on N, target $50.
Merrill Lynch:
- Raised ATYT, ALTR, BRCM, AMIS, MXIM to Buy.
Legg Mason:
- Raised IGT to Buy, target $35.
- Rated WMS Buy, target $33.
Prudential:
- Downgraded NCX to Underweight, target $35.
- Downgraded WLK to Underweight, target $24.
Bear Stearns:
- Rated CMOS Outperform, target $12.
- Rated MTSN Outperform, target $12.
Deutsche Bank:
- Raised IPG to Buy, target $16.
Piper Jaffray:
- Raised JCP to Outperform, target $63.
JP Morgan:
- Rated ATU Overweight.
UBS:
- Downgraded RSAS to Reduce, target $11.
- Raised BHI to Buy, target $55.
- Reiterated Buy on IBM, target $107.
- Reiterated Buy on RIMM, target $95.
No comments:
Post a Comment